Comparative study between 20ml of 0.5% ropivacaine and 20ml of 0.5% levobupivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 6, Pages 2535-2546
AbstractAim: This study is aimed to compare the effects between 20ml of 0.5% Ropivacaine and 20ml
of 0.5% Levobupivacaine in ultrasound guided supraclavicular brachial plexus block for
Upper limb surgeries.
Methodology: It was a prospective double blinded randomized controlled study in sixty adult
patients undergoing upper limb surgeries admitted in Rajah Muthiah Medical college and
hospital from November 2020 to November 2022.
Result: Significant earlier onset of sensory blockade (p=0.001) and motor blockade (p=0.001),
prolonged duration of sensory and motor blockade (p=0.001) was observed in group of
patients receiving 0.5% levobupivacaine compared to 0.5% ropivacaine. Intraoperatively
throughout the study heart rate (HR), systolic blood pressure (SBP) and diastolic blood
pressure (DBP) were comparable in both the groups and found no statistically significant
difference (p>0.05). The heart rate, systolic and diastolic blood pressure for both the groups
were also compared postoperatively and observed no significant statistical difference (p>0.05).
No adverse effects were observed in both the groups.
Conclusion: 0.5% levobupivacaine used in ultrasound guided supraclavicular brachial plexus
block for upper limb surgeries provides rapid onset of sensory and motor blockade and
prolonged duration of analgesia compared to 0.5% ropivacaine
- Article View: 17
- PDF Download: 29